From: Prostate specific antigen test uptake: a cross sectional study on elderly men in Western Iran
B | S.E. | Wald | P | OR | 95% C.I | ||
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
Step 1 | |||||||
Benefits | 0.187 | 0.063 | 8.818 | 0.003 | 1.205 | 1.066 | 1.364 |
Barriers | −0.073 | 0.070 | 1.091 | 0.296 | 0.930 | 0.810 | 1.066 |
Susceptibility | −0.261 | 0.140 | 3.500 | 0.061 | 0.770 | 0.585 | 1.013 |
Severity | 0.223 | 0.091 | 6.044 | 0.014 | 1.249 | 1.046 | 1.492 |
Self-efficacy | 0.008 | 0.078 | 0.010 | 0.921 | 1.008 | 0.865 | 1.175 |
Cues to action | 0.707 | 0.134 | 27.876 | < 0.001 | 2.029 | 1.560 | 2.638 |
Step 2 | |||||||
Benefits | 0.187 | 0.063 | 8.936 | 0.003 | 1.206 | 1.067 | 1.364 |
Barriers | −0.075 | 0.067 | 1.277 | 0.258 | 0.928 | 0.814 | 1.057 |
Susceptibility | −0.261 | 0.139 | 3.495 | 0.062 | 0.771 | 0.586 | 1.013 |
Severity | 0.223 | 0.090 | 6.069 | .014 | 1.250 | 1.047 | 1.492 |
Cues to action | 0.708 | 0.134 | 28.128 | < 0.001 | 2.031 | 1.563 | 2.639 |
Step 3 | |||||||
Benefits | 0.175 | 0.061 | 8.230 | 0.004 | 1.191 | 1.057 | 1.343 |
Susceptibility | −0.217 | 0.133 | 2.665 | 0.103 | 0.805 | 0.620 | 1.045 |
Severity | 0.229 | 0.090 | 6.448 | 0.011 | 1.258 | 1.054 | 1.502 |
Cues to action | 0.745 | 0.131 | 32.284 | < 0.001 | 2.106 | 1.629 | 2.723 |
Step 4 | |||||||
Benefits | 0.125 | 0.052 | 5.864 | 0.015 | 1.133 | 1.024 | 1.253 |
Severity | 0.131 | 0.063 | 4.325 | 0.038 | 1.140 | 1.008 | 1.290 |
Cues to action | 0.677 | 0.123 | 30.270 | < 0.001 | 1.967 | 1.546 | 2.504 |